BioCorRx Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 6/06/2017
Contact Info
  • 2390 East Orangewood Avenue
  • Suite 575
  • Anaheim, CA 92806

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001443863
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8093 - Specialty outpatient clinics, misc
Incorporated In: NV, USA
Year of Inc. 2008
Employees 3 a/o Dec 14, 2016
Company Officers/Contacts
Brady Granier CEO, President
Lourdes Felix CFO, COO
Tom Welch VP, Ops.
Company Directors
Kent Emry Chairman, Independent Director
Lourdes Felix
Brady Granier
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States
Securities Counsel
Lucosky Brookman LLP OTCQX Sponsor
101 Wood Avenue South
5th Floor
Woodbridge, NJ, 08830
United States
Investor Relations Firm
Crescendo Communications LLC
626 RXR Plaza
Uniondale, NY, 11566
United States
Company History
  • Formerly=Fresh Start Private Management, Inc. until 2-2014
  • Formerly=Cetrone Energy Co. until 8-2010
BICX Security Details
Share Structure
Market Value1 $23,608,288 a/o Oct 20, 2017
Authorized Shares 525,000,000 a/o Oct 10, 2017
Outstanding Shares 242,136,285 a/o Oct 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 110,031,021 a/o Jun 27, 2016
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 109 a/o Apr 13, 2017
Short Selling Data
Short Interest 10,905 (-54.93%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security